Cava Group's Expansion Plans Drive Stock Surge
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 25 2026
0mins
Should l Buy CAVA?
Source: Fool
- Significant Revenue Growth: Cava Group reported a 21.2% year-over-year revenue increase to $272.8 million in its fiscal fourth quarter, primarily driven by new store openings and higher sales at existing locations, indicating strong brand appeal among consumers.
- Accelerated Store Expansion: The company opened 24 new restaurants in the fourth quarter and a total of 72 in fiscal 2025, bringing its total store count to 439 as of December 28, further solidifying its market position.
- Slight Same-Store Sales Increase: Despite a 1.4% decline in guest traffic, Cava's same-store sales rose by 0.5%, attributed to menu price increases and an optimized product mix, reflecting consumer preference for healthy dining options.
- Optimistic Future Outlook: Management plans to open approximately 75 new restaurants in fiscal 2026 and expects existing location sales to rise by about 4%, which will drive adjusted EBITDA from $152.8 million in 2025 to between $176 million and $184 million, showcasing strong growth potential.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CAVA?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CAVA
Wall Street analysts forecast CAVA stock price to fall
18 Analyst Rating
12 Buy
6 Hold
0 Sell
Moderate Buy
Current: 93.110
Low
60.00
Averages
73.29
High
86.00
Current: 93.110
Low
60.00
Averages
73.29
High
86.00
About CAVA
CAVA Group, Inc. is a category-defining Mediterranean fast-casual restaurant brand. The Company’s Mediterranean cuisine unites taste and health, with a menu that features chef-curated and customizable bowls and pitas. Its dips, spreads, and dressings are centrally produced and sold in grocery stores. Its menu offers a range of dietary preferences, from hearty and indulgent to vegan, vegetarian, gluten-free, dairy-free, paleo, keto, and nut-free diets. Its guests can choose a chef-curated meal or a build-your-own-bowl or pita using its 38 ingredients with over 17.4 billion combinations. It has developed a multi-channel experience that consists of in-restaurant dining, digital pick-up, drive-thru pick-up in select restaurants, delivery, catering, and consumer packaged goods offerings, fully supported by its digital infrastructure. It operates two production facilities: one in Maryland and one in Virginia. It operates in approximately 26 states and the District of Columbia.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Stocks Set for Higher Open as Tech Stocks Surge on Intel Earnings
- Tech Stock Surge: Intel shares soared 25% this morning under CEO Lip Bu Tan's leadership, demonstrating a robust recovery over the past 13 months, which is likely to enhance investor confidence and attract further investments.
- Market Dynamics: With oil prices and bond yields declining, optimism surrounding potential peace talks between the U.S. and Iran has emerged, while President Trump announced an extension of the ceasefire between Israel and Lebanon, contributing to a positive market sentiment that may drive stock prices higher.
- Procter & Gamble's Strong Performance: Procter & Gamble reported better-than-expected quarterly earnings and revenue, with volume growth for the first time in a year, particularly in beauty products, leading to a more than 3% increase in stock price, indicating a recovery in consumer demand and the effectiveness of the company's strategic initiatives.
- Analyst Rating Adjustments: Barclays cut Honeywell's price target from $255 to $243, citing the need for improvement in its aerospace division to regain investor trust, while Dover's price target was raised to $230 due to strong Q1 results, reflecting market confidence in its future growth prospects.
See More
Roth Capital Initiates Coverage on CAVA Group with Buy Rating
- Coverage Initiation: Roth Capital has initiated coverage on CAVA Group (CAVA) with a Buy rating and a price target of $106, as analyst JP Wollam believes the restaurant stock has significant upside potential following a healthy outlook for 2026, reflecting strong market confidence.
- Optimistic Outlook: Wollam noted that CAVA's guidance is better than its fast-casual peers and may be conservative, with expectations for mature units (>3 years) to achieve over 5% comp growth in 2026, indicating the company's competitive strength and growth potential in the market.
- Expansion Plans: Roth Capital projects that CAVA will have nearly 1,000 units by 2030, with an annual EBITDA of almost $500 million, showcasing the brand's ability to compound growth beyond its physical footprint, further boosting investor confidence.
- Market Performance: Although CAVA shares fell 0.3% in Wednesday afternoon trading, the stock has risen over 60% year-to-date, demonstrating strong market performance and positive investor sentiment.
See More
Latest Rating Changes on Wall Street
- Airbnb Upgrade: Wells Fargo upgraded Airbnb from equal weight to overweight, projecting revenue growth of 6% to 11% and EPS growth of 7% to 12% by 2027, indicating strong innovation and market potential.
- Positive Outlook for SharonAI: Compass Point initiated coverage on SharonAI with a buy rating, highlighting that its first major contract will drive scale and that its Australian capacity build provides a credible market base for deployment.
- Biogen's Multiple Catalysts: UBS upgraded Biogen to buy with a price target of $225, citing increasing confidence in several pipeline catalysts expected to drive stock price higher over the next 12-15 months.
- Twilio's Strategic Improvement: Bank of America upgraded Twilio from underperform to buy with a price target of $190, believing its strategic positioning in AI will lead to positive growth inflections for the company.
See More
CAVA Group Anticipates Strong Q1 Earnings Amid Growth
- Strong Revenue Expectations: CAVA is projected to report Q1 revenue of $416 million and EPS of $0.17, reflecting steady traffic and new unit growth, indicating the company's sustained competitiveness in the market.
- Outstanding Market Performance: CAVA's stock has surged 61% year-to-date, significantly outperforming the S&P 500's 4%, which reflects investor confidence in the company's growth prospects, although analysts generally expect guidance to remain conservative.
- Product Launch Catalysts: Analysts noted that the introduction of the Glazed Salmon menu and new protein offerings could serve as catalysts for performance growth, further enhancing the company's appeal in the fast-casual dining sector.
- Valuation Risk Warning: Despite the optimistic growth outlook, Northcoast analysts issued a Sell rating, cautioning that the current valuation has outpaced CAVA's potential, and declining organic sales could pressure its pricing power.
See More
Sweetgreen Introduces High-Protein Wraps to Revitalize Sales
- Sales Growth Potential: Cava's introduction of grilled steak in Q2 2024 boosted same-store sales from 2.3% to 14.4%, indicating that new menu items can significantly drive sales; if Sweetgreen successfully launches wraps, it could experience similar growth.
- Market Competitive Pressure: Sweetgreen has faced severe market challenges as rising fast-food prices and increased competition from casual dining have led to a sharp decline in same-store sales, forcing the company to close some locations as leases expire, highlighting the tough environment it operates in.
- Product Innovation Strategy: Sweetgreen plans to introduce high-protein wraps in select New York City locations, priced between $11 and $15, leveraging existing ingredients in a trendier format to attract younger consumers and enhance brand appeal and market share.
- Young Consumer Preference: The wrap strategy taps into the popularity of wraps among younger demographics, and with reasonable pricing and high protein content, it may attract consumers on GLP-1 weight loss drugs, potentially creating new growth opportunities for Sweetgreen.
See More
Sweetgreen Introduces New Menu to Boost Sales
- New Menu Drives Sales: Sweetgreen's introduction of high-protein wraps, priced between $11 and $15 in select NYC test markets, aims to attract younger consumers and boost sales amid health food trends.
- Intensifying Market Competition: As competition from fast food and casual dining increases, Sweetgreen has seen significant declines in same-store sales, forcing the company to close some locations as leases expire to manage financial pressures.
- Successful Case Study: Cava's launch of new menu items led to a jump in same-store sales from 2.3% to 14.4% in Q2 2024, providing a potential success template for Sweetgreen, indicating that new products can significantly enhance customer traffic and sales.
- Investment Risk Assessment: While Sweetgreen's stock is considered highly speculative, the potential success of the wrap strategy could lead to substantial upside in stock price, making it worth a small position for investors to consider.
See More
Stocks Set for Higher Open as Tech Stocks Surge on Intel Earnings
- Tech Stock Surge: Intel shares soared 25% this morning under CEO Lip Bu Tan's leadership, demonstrating a robust recovery over the past 13 months, which is likely to enhance investor confidence and attract further investments.
- Market Dynamics: With oil prices and bond yields declining, optimism surrounding potential peace talks between the U.S. and Iran has emerged, while President Trump announced an extension of the ceasefire between Israel and Lebanon, contributing to a positive market sentiment that may drive stock prices higher.
- Procter & Gamble's Strong Performance: Procter & Gamble reported better-than-expected quarterly earnings and revenue, with volume growth for the first time in a year, particularly in beauty products, leading to a more than 3% increase in stock price, indicating a recovery in consumer demand and the effectiveness of the company's strategic initiatives.
- Analyst Rating Adjustments: Barclays cut Honeywell's price target from $255 to $243, citing the need for improvement in its aerospace division to regain investor trust, while Dover's price target was raised to $230 due to strong Q1 results, reflecting market confidence in its future growth prospects.
See More
Roth Capital Initiates Coverage on CAVA Group with Buy Rating
- Coverage Initiation: Roth Capital has initiated coverage on CAVA Group (CAVA) with a Buy rating and a price target of $106, as analyst JP Wollam believes the restaurant stock has significant upside potential following a healthy outlook for 2026, reflecting strong market confidence.
- Optimistic Outlook: Wollam noted that CAVA's guidance is better than its fast-casual peers and may be conservative, with expectations for mature units (>3 years) to achieve over 5% comp growth in 2026, indicating the company's competitive strength and growth potential in the market.
- Expansion Plans: Roth Capital projects that CAVA will have nearly 1,000 units by 2030, with an annual EBITDA of almost $500 million, showcasing the brand's ability to compound growth beyond its physical footprint, further boosting investor confidence.
- Market Performance: Although CAVA shares fell 0.3% in Wednesday afternoon trading, the stock has risen over 60% year-to-date, demonstrating strong market performance and positive investor sentiment.
See More
Latest Rating Changes on Wall Street
- Airbnb Upgrade: Wells Fargo upgraded Airbnb from equal weight to overweight, projecting revenue growth of 6% to 11% and EPS growth of 7% to 12% by 2027, indicating strong innovation and market potential.
- Positive Outlook for SharonAI: Compass Point initiated coverage on SharonAI with a buy rating, highlighting that its first major contract will drive scale and that its Australian capacity build provides a credible market base for deployment.
- Biogen's Multiple Catalysts: UBS upgraded Biogen to buy with a price target of $225, citing increasing confidence in several pipeline catalysts expected to drive stock price higher over the next 12-15 months.
- Twilio's Strategic Improvement: Bank of America upgraded Twilio from underperform to buy with a price target of $190, believing its strategic positioning in AI will lead to positive growth inflections for the company.
See More
CAVA Group Anticipates Strong Q1 Earnings Amid Growth
- Strong Revenue Expectations: CAVA is projected to report Q1 revenue of $416 million and EPS of $0.17, reflecting steady traffic and new unit growth, indicating the company's sustained competitiveness in the market.
- Outstanding Market Performance: CAVA's stock has surged 61% year-to-date, significantly outperforming the S&P 500's 4%, which reflects investor confidence in the company's growth prospects, although analysts generally expect guidance to remain conservative.
- Product Launch Catalysts: Analysts noted that the introduction of the Glazed Salmon menu and new protein offerings could serve as catalysts for performance growth, further enhancing the company's appeal in the fast-casual dining sector.
- Valuation Risk Warning: Despite the optimistic growth outlook, Northcoast analysts issued a Sell rating, cautioning that the current valuation has outpaced CAVA's potential, and declining organic sales could pressure its pricing power.
See More
Sweetgreen Introduces High-Protein Wraps to Revitalize Sales
- Sales Growth Potential: Cava's introduction of grilled steak in Q2 2024 boosted same-store sales from 2.3% to 14.4%, indicating that new menu items can significantly drive sales; if Sweetgreen successfully launches wraps, it could experience similar growth.
- Market Competitive Pressure: Sweetgreen has faced severe market challenges as rising fast-food prices and increased competition from casual dining have led to a sharp decline in same-store sales, forcing the company to close some locations as leases expire, highlighting the tough environment it operates in.
- Product Innovation Strategy: Sweetgreen plans to introduce high-protein wraps in select New York City locations, priced between $11 and $15, leveraging existing ingredients in a trendier format to attract younger consumers and enhance brand appeal and market share.
- Young Consumer Preference: The wrap strategy taps into the popularity of wraps among younger demographics, and with reasonable pricing and high protein content, it may attract consumers on GLP-1 weight loss drugs, potentially creating new growth opportunities for Sweetgreen.
See More
Sweetgreen Introduces New Menu to Boost Sales
- New Menu Drives Sales: Sweetgreen's introduction of high-protein wraps, priced between $11 and $15 in select NYC test markets, aims to attract younger consumers and boost sales amid health food trends.
- Intensifying Market Competition: As competition from fast food and casual dining increases, Sweetgreen has seen significant declines in same-store sales, forcing the company to close some locations as leases expire to manage financial pressures.
- Successful Case Study: Cava's launch of new menu items led to a jump in same-store sales from 2.3% to 14.4% in Q2 2024, providing a potential success template for Sweetgreen, indicating that new products can significantly enhance customer traffic and sales.
- Investment Risk Assessment: While Sweetgreen's stock is considered highly speculative, the potential success of the wrap strategy could lead to substantial upside in stock price, making it worth a small position for investors to consider.
See More
